Results 141 to 150 of about 107,774 (274)

β3‐adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 10, Page 2497-2517, May 2026.
The β3‐adrenoceptors agonist BRL37344 promotes lung maturation, preventing the progression of experimental bronchopulmonary dysplasia. Absract Background and Purpose Bronchopulmonary dysplasia (BPD) affects premature newborns, particularly those receiving supplemental oxygen therapy.
Alessandro Pini   +14 more
wiley   +1 more source

Relapse and Neurological Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: A Retrospective Secondary Analysis of a Japanese Nationwide Epidemiologic Survey

open access: yesClinical and Experimental Neuroimmunology, Volume 17, Issue 2, May 2026.
ABSTRACT Background Some patients with myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) experience multiple relapses and poor prognoses; however, the factors associated with these outcomes are unclear. This study aimed to identify factors associated with relapse and neurological prognosis in patients with MOGAD.
Masashi Nakamura   +4 more
wiley   +1 more source

Cases of AQP4‐Antibody‐Positive Neuromyelitis Optica Spectrum Disorder Successfully Discontinuing Steroids With Satralizumab Treatment: Considerations on the Method of Tapering for Steroids After the Introduction of Satralizumab

open access: yesClinical and Experimental Neuroimmunology, Volume 17, Issue 2, May 2026.
ABSTRACT Background Satralizumab is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD). However, there are currently no standardized guidelines regarding the method or speed of steroid tapering after its introduction. In 2023, we proposed a method to commence tapering prednisolone at a rate of 1 mg every 4 weeks, starting 8 weeks ...
Kiyotaka Nakamagoe   +4 more
wiley   +1 more source

Tumefactive Demyelination in MOG Ab–Associated Disease, Multiple Sclerosis, and AQP-4-IgG–Positive Neuromyelitis Optica Spectrum Disorder [PDF]

open access: green, 2023
Laura Cacciaguerra   +17 more
openalex   +1 more source

Lingual Dyskinesia as the Presenting Feature of Acquired Demyelinating Syndrome: A Case Report and Review of Differential Diagnoses

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Briana Davis   +3 more
wiley   +1 more source

Cerebrospinal Fluid sCD27 as a Biomarker of Neuroinflammatory Disease: A Systematic Review and Meta‐Analysis

open access: yesJournal of Neurochemistry, Volume 170, Issue 5, May 2026.
Neuroinflammatory diseases of the CNS are difficult to diagnose, and current CSF biomarkers lack sensitivity across conditions. Soluble CD27 (sCD27), a marker of adaptive immune activation, has emerged as a promising candidate, but its clinical utility remains uncertain.
Nadia Damholt Savino   +5 more
wiley   +1 more source

New Insights into Neuromyelitis Optica [PDF]

open access: diamond, 2011
Woojun Kim, Su‐Hyun Kim, Ho Jin Kim
openalex   +1 more source

Unveiling the Potential of Reduced Graphene Oxide in Self‐Powered Photodetectors

open access: yesChemPhysChem, Volume 27, Issue 7, 14 April 2026.
Self‐powered photodetectors have emerged as advanced devices, gathering significant attention in the field of optoelectronics, particularly for their potential in power‐scarce environments. These devices can detect light and generate an electrical current with minimal or no external power supply.
Bitap Raj Thakuria   +3 more
wiley   +1 more source

Neuromyelitis optica(case report)

open access: diamond, 2020
Gülnar Aliyeva, Turkan Sultanova
openalex   +1 more source

Schwarzschild black hole in King’s dark matter halo

open access: yesEuropean Physical Journal C: Particles and Fields
This study delves into the intricate properties of a Schwarzschild black hole enveloped by King’s dark matter in an isotropic configuration. The thermodynamic characteristics of this black hole are meticulously analyzed, and the dynamics of massive and ...
S. Zare   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy